MarketPulse

Japan regulatory approval

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Kyowa Kirin, Kura Oncology Launch Japanese Phase 2 Trial for FDA-Approved Ziftomenib

Kyowa Kirin and Kura Oncology begin Japanese Phase 2 registrational trial for ziftomenib in relapsed/refractory NPM1-mutated AML, following FDA approval.
KURAPhase 2 clinical trialhematologic malignancies
GlobeNewswire Inc.GlobeNewswire Inc.··Pharming Group N.V.

Pharming Wins Japan Approval for Joenja, First APDS Treatment for Young Children

Pharming secures Japan approval for Joenja, first APDS treatment for children aged 4-11 globally, based on positive Phase III data showing lymphadenopathy reduction and immune function improvement.
PHARpediatric treatmentorphan drug